Inhibrx Biosciences Inc. (INBX)
$87.08-3.81%Close
SELLCRISIS · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.3B
- Beta
- 3.82
- P/E (TTM)
- -9.81
- Short % float
- 31.59%
- Days to cover
- 11.8
- SI change
- +1.1%
- 1W
- -6.78%
- 1M
- -21.17%
- vs SPY 1W
- -6.64%
- vs SPY 1M
- -23.68%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on INBX?
- LOPJLB’s latest quantitative signal on Inhibrx Biosciences Inc. (INBX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is INBX in?
- Inhibrx Biosciences Inc. (INBX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Inhibrx Biosciences Inc. (INBX) do?
- Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric wa…